Mega Genomics (6667 HK)

Analysis

Health Care • China

Mega Genomics is a genetic testing platform company in China that focuses on consumer genetic testing and cancer screening services. The company offers a wide range of testing services, including those for nutrition and metabolism, cancer risk assessment, chronic disease susceptibility, and infectious disease diagnosis. It also provides in vitro diagnostics (IVD) pipeline products. Mega Genomics is headquartered in Beijing, China, and was founded in 2016.

Refresh

Exchange Announcement • 14 Oct 2026 20:53

Next Day Disclosure Returns

Exchange Announcement • 13 Oct 2026 20:51

Next Day Disclosure Returns

Exchange Announcement • 12 Oct 2026 18:01

Next Day Disclosure Returns

Exchange Announcement • 09 Oct 2026 17:32

Next Day Disclosure Returns

Exchange Announcement • 08 Oct 2026 21:42

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00